Phospholipids in Vaccines

Time: 10:30 am
day: Conference Day One

Details:

  • The amphiphilic nature and safety profile of phospholipids make them ideal excipients for LNP formulations
  • The lipid composition of LNPs and their impact on the delivery of mRNA
  • Helper lipid selection can modulate the properties of LNP delivery and stability
  • DSPC with its high phase transition temperature provides excellent colloidal stability to LNPs
  • DOPE can enhance endosomal escape, while other phospholipids can target specific tissues
  • Phospholipids and their role in delivering adjuvanted liposomal vaccines

Speakers: